| __timestamp | Biogen Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 293000 |
| Thursday, January 1, 2015 | 2012800000 | 1002000 |
| Friday, January 1, 2016 | 1973300000 | 888000 |
| Sunday, January 1, 2017 | 2253600000 | 19623000 |
| Monday, January 1, 2018 | 2597200000 | 30421000 |
| Tuesday, January 1, 2019 | 2280600000 | 34794000 |
| Wednesday, January 1, 2020 | 3990900000 | 28304000 |
| Friday, January 1, 2021 | 2501200000 | 56886000 |
| Saturday, January 1, 2022 | 2231100000 | 100894000 |
| Sunday, January 1, 2023 | 2702600000 | 159765000 |
| Monday, January 1, 2024 | 2041800000 |
Data in motion
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Biogen Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D expenditures. Biogen, a stalwart in the industry, consistently invested heavily, peaking in 2020 with a 58% increase from 2014. In contrast, Viridian, a burgeoning player, showcased a remarkable growth story, with R&D spending skyrocketing by over 54,000% from 2014 to 2023. This stark difference underscores the diverse strategies of established giants and emerging innovators. While Biogen's steady investments reflect its commitment to sustaining its market leadership, Viridian's exponential growth in R&D spending highlights its aggressive pursuit of breakthroughs. As the biotech sector continues to expand, these investment patterns offer a glimpse into the future of medical innovation.
Comparing Innovation Spending: Eli Lilly and Company and Biogen Inc.
Research and Development Expenses Breakdown: Biogen Inc. vs Sarepta Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Axsome Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Biogen Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Biogen Inc. and Evotec SE Allocate Funds
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Pharming Group N.V. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for HUTCHMED (China) Limited and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?